Dutch company Kiadis Pharma has appointed Jan Feijen as its new chief operations officer with responsibility for manufacturing, supply chain, QA and project management.
Feijen arrives at Kiadis Pharma from Janssen where he was vice president manufacturing and technical operations, platform lead vaccines and advanced therapies.
He said: “I am very pleased to be joining Kiadis Pharma at this important time in its development. With the company’s pivotal phase III trial with ATIR101 now underway, it is vital that the necessary steps are taken to ensure everything continues to run smoothly and that we have all logistics in hand ready to roll out commercially in the future.”
Prior to his time at Janssen, Feijen held positions for the likes of Crucell, Avebe and Gist Brocades.
Arthur Lahr, CEO at Kiadis Pharma, said: “We are very pleased that an industry leader like Jan has accepted this opportunity to join Kiadis Pharma. His vast experience in pharma production precedes him, and his experience in running complex, just-in-time logistics will be of great value in scaling up our patient specific supply chain.”